Biotron Limited (ASX:BIT)
Australia · Delayed Price · Currency is AUD 0.0020
0.00 (0.00%)
Aug 11, 2026, 2:08 PM AEST
Biotron Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 1.64 | 0.93 | 0.39 | 3.98 | 1.74 | 4.21 |
Cash & Short-Term Investments | 1.64 | 0.93 | 0.39 | 3.98 | 1.74 | 4.21 |
Cash Growth | 76.33% | 136.95% | -90.13% | 128.80% | -58.64% | -45.04% |
Other Receivables | - | 0.01 | 0.02 | 0.02 | - | - |
Receivables | - | 0.01 | 0.02 | 0.02 | - | - |
Prepaid Expenses | - | 0.02 | 0.02 | 0.02 | 0.02 | 0.05 |
Other Current Assets | 0.06 | - | - | - | - | - |
Total Current Assets | 1.71 | 0.96 | 0.43 | 4.03 | 1.76 | 4.26 |
Property, Plant & Equipment | 0 | 0 | 0.01 | 0.05 | 0.09 | 0.03 |
Other Long-Term Assets | 0.02 | 0.02 | 0.05 | 0.05 | 0.05 | 0.03 |
Total Assets | 3.86 | 0.98 | 0.49 | 4.14 | 1.91 | 4.33 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Accounts Payable | 0.39 | 0.09 | 0.29 | 0.29 | 0.31 | 0.14 |
Accrued Expenses | 0.27 | 0.34 | 0.44 | 0.63 | 0.41 | 0.31 |
Current Portion of Leases | - | - | 0.01 | 0.04 | 0.03 | 0.01 |
Total Current Liabilities | 1.16 | 0.43 | 0.74 | 0.96 | 0.75 | 0.45 |
Long-Term Leases | - | - | - | 0.01 | 0.04 | - |
Other Long-Term Liabilities | - | - | - | - | 0.02 | 0.01 |
Total Liabilities | 1.16 | 0.43 | 0.74 | 0.96 | 0.81 | 0.46 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Common Stock | 61.95 | 59.32 | 56.91 | 56.89 | 52.84 | 52.84 |
Additional Paid-In Capital | - | - | 1.52 | 1.53 | - | - |
Retained Earnings | -59.69 | -58.77 | -58.68 | -55.26 | -51.84 | -49.09 |
Comprehensive Income & Other | 0.44 | - | - | 0.02 | 0.09 | 0.11 |
Shareholders' Equity | 2.7 | 0.55 | -0.24 | 3.17 | 1.09 | 3.86 |
Total Liabilities & Equity | 3.86 | 0.98 | 0.49 | 4.14 | 1.91 | 4.33 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Total Debt | - | - | 0.01 | 0.05 | 0.08 | 0.01 |
Net Cash (Debt) | 1.64 | 0.93 | 0.39 | 3.94 | 1.66 | 4.2 |
Net Cash Growth | 76.33% | 141.32% | -90.20% | 136.70% | -60.42% | -44.80% |
Net Cash Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
Filing Date Shares Outstanding | 2,409 | 1,327 | 902.28 | 901.94 | 701.93 | 701.93 |
Total Common Shares Outstanding | 2,409 | 1,327 | 902.28 | 901.94 | 701.93 | 701.93 |
Working Capital | 0.54 | 0.53 | -0.31 | 3.08 | 1.01 | 3.81 |
Book Value Per Share | 0.00 | 0.00 | -0.00 | 0.00 | 0.00 | 0.01 |
Tangible Book Value | 0.57 | 0.55 | -0.24 | 3.17 | 1.09 | 3.86 |
Tangible Book Value Per Share | 0.00 | 0.00 | -0.00 | 0.00 | 0.00 | 0.01 |
Machinery | - | 0.76 | 0.76 | 0.76 | 0.76 | 0.76 |